id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
2433404,718772aa-eecf-4d8c-88bf-cd2fa3f455aa,Q1,"WILLIAMS AND JENSEN, PLLC",41454,MERCK & CO INC,2020,first_quarter,MMM,"Payment policies for Part B prescription drugs;  Rebates and co-pays for Medicare Part D drug benefits; Possible revisions in structure and operation of Medicare and Medicaid drug policies.  S. 2543, Prescription Drug Pricing Reduction Act (PDPRA) of 2019 and H.R. 3, Lower Drug Costs Now Act of 2019.  Policies impacting U.S. address to the Covid-19 pandemic, including H.R. 604 Coronavirus Preparedness and Response Supplemental Appropriations Act, Public Law No: 116-123.; H. R . 6201  Families First Coronavirus Response Act, Public Law No: 116-127; and H. R. 748  CARES Act, Public Law No: 116-136.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,White House Office",80000,,0,0,2020-04-17T16:20:51.220000-04:00